Vijaya Diagnostic [VIJAYA] vs Strides Pharma [STAR] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Vijaya Diagnostic Centre Ltd. wins in 6 metrics, Strides Pharma Science Ltd. wins in 14 metrics, with 0 ties. Strides Pharma Science Ltd. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Vijaya Diagnostic Centre Ltd. | Strides Pharma Science Ltd. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 67.41 | 19.26 | Strides Pharma Science Ltd. |
| Price-to-Book Ratio | 12.37 | 3.57 | Strides Pharma Science Ltd. |
| Debt-to-Equity Ratio | 42.22 | 65.79 | Vijaya Diagnostic Centre Ltd. |
| PEG Ratio | 25.06 | 0.11 | Strides Pharma Science Ltd. |
| EV/EBITDA | 39.80 | 12.80 | Strides Pharma Science Ltd. |
| Profit Margin (TTM) | 20.73% | 10.82% | Vijaya Diagnostic Centre Ltd. |
| Operating Margin (TTM) | 30.07% | 15.51% | Vijaya Diagnostic Centre Ltd. |
| EBITDA Margin (TTM) | 30.07% | 15.51% | Vijaya Diagnostic Centre Ltd. |
| Return on Equity | 17.90% | 138.93% | Strides Pharma Science Ltd. |
| Return on Assets (TTM) | 11.23% | 59.41% | Strides Pharma Science Ltd. |
| Free Cash Flow (TTM) | $1.29B | $4.42B | Strides Pharma Science Ltd. |
| Dividend Yield | 0.30% | 0.74% | Strides Pharma Science Ltd. |
| 1-Year Return | 36.83% | 37.07% | Strides Pharma Science Ltd. |
| Price-to-Sales Ratio (TTM) | 13.94 | 2.09 | Strides Pharma Science Ltd. |
| Enterprise Value | $107.20B | $108.98B | Strides Pharma Science Ltd. |
| EV/Revenue Ratio | 13.96 | 2.31 | Strides Pharma Science Ltd. |
| Gross Profit Margin (TTM) | 88.29% | 61.25% | Vijaya Diagnostic Centre Ltd. |
| Revenue per Share (TTM) | $75 | $513 | Strides Pharma Science Ltd. |
| Earnings per Share (Diluted) | $15.44 | $55.51 | Strides Pharma Science Ltd. |
| Beta (Stock Volatility) | 0.01 | 0.26 | Vijaya Diagnostic Centre Ltd. |
Vijaya Diagnostic Centre Ltd. vs Strides Pharma Science Ltd. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Vijaya Diagnostic Centre Ltd. | 6.25% | 1.43% | 10.89% | 35.86% | 27.70% | 22.74% |
| Strides Pharma Science Ltd. | -4.99% | -6.34% | 4.82% | 29.82% | 20.88% | 18.64% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Vijaya Diagnostic Centre Ltd. | 36.83% | 243.17% | 108.69% | 108.69% | 108.69% | 108.69% |
| Strides Pharma Science Ltd. | 37.07% | 209.26% | 41.15% | 7.56% | 221.49% | 368.70% |
Performance & Financial Health Analysis: Vijaya Diagnostic Centre Ltd. vs Strides Pharma Science Ltd.
| Metric | VIJAYA | STAR |
|---|---|---|
| Market Information | ||
| Market Cap | ₹109.64B | ₹98.28B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 111,888 | 306,327 |
| 90 Day Avg. Volume | 123,950 | 294,978 |
| Last Close | ₹1,359.40 | ₹1,027.20 |
| 52 Week Range | ₹848.00 - ₹1,380.00 | ₹768.65 - ₹1,231.00 |
| % from 52W High | -1.49% | -16.56% |
| All-Time High | ₹1,380.00 (Jun 04, 2026) | ₹1,675.00 (Oct 14, 2024) |
| % from All-Time High | -1.49% | -38.67% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.21% | 0.04% |
| Quarterly Earnings Growth | 0.23% | 1.30% |
| Financial Health | ||
| Profit Margin (TTM) | 0.21% | 0.11% |
| Operating Margin (TTM) | 0.30% | 0.16% |
| Return on Equity (TTM) | 0.18% | 1.39% |
| Debt to Equity (MRQ) | 42.22 | 65.79 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹84.14 | ₹299.06 |
| Cash per Share (MRQ) | ₹28.88 | ₹24.68 |
| Operating Cash Flow (TTM) | ₹2.04B | ₹36.02B |
| Levered Free Cash Flow (TTM) | ₹1.43B | ₹35.93B |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.30% | 0.74% |
| Last 12-Month Dividend | ₹3.00 | ₹6.50 |
Valuation & Enterprise Metrics Analysis: Vijaya Diagnostic Centre Ltd. vs Strides Pharma Science Ltd.
| Metric | VIJAYA (Apr 24, 2026) | STAR (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 67.41 | 19.26 |
| Forward P/E | 50.66 | 14.73 |
| PEG Ratio | 25.06 | 0.11 |
| Price to Sales (TTM) | 13.94 | 2.09 |
| Price to Book (MRQ) | 12.37 | 3.57 |
| Market Capitalization | ||
| Market Capitalization | ₹109.64B | ₹98.28B |
| Enterprise Value | ₹107.20B | ₹108.98B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 13.96 | 2.31 |
| Enterprise to EBITDA | 39.80 | 12.80 |
| Risk & Other Metrics | ||
| Beta | 0.01 | 0.26 |
| Book Value per Share (MRQ) | ₹84.14 | ₹299.06 |
Financial Statements Comparison: Vijaya Diagnostic Centre Ltd. vs Strides Pharma Science Ltd.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | VIJAYA (2025) | STAR (2025) |
|---|---|---|
| Revenue/Sales | 6.81B | 43.92B |
| Cost of Goods Sold | 847.64M | 21.34B |
| COGS % of Revenue | 12.4% | 48.6% |
| Gross Profit | 5.96B | 22.58B |
| Gross Margin | 87.6% | 51.4% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | 2.03B | 5.80B |
| Operating Margin | 29.8% | 13.2% |
| EBITDA | 2.77B | 7.90B |
| EBITDA Margin | 40.7% | 18.0% |
| Pre-Tax Income | 1.93B | 4.87B |
| Pre-Tax Income % of Revenue | 28.4% | 11.1% |
| Income Tax | 493.71M | 775.16M |
| Income Tax % of Revenue | 7.3% | 1.8% |
| Net Income (Profit) | 1.44B | 35.98B |
| Profit Margin | 21.1% | 81.9% |
Balance Sheet & Liquidity Metrics
| Metric | VIJAYA (2025) | STAR (2025) |
|---|---|---|
| Cash & Equivalents | 127.94M | 1.13B |
| Total Current Assets | 3.07B | 31.02B |
| Total Current Assets % of Revenue | 45.1% | 70.6% |
| Total Current Liabilities | 1.63B | 25.92B |
| Total Current Liabilities % of Revenue | 23.9% | 59.0% |
| Long-Term Debt | 2.96B | 6.23B |
| Long-Term Debt % of Revenue | 43.5% | 14.2% |
| Total Shareholders Equity | 7.99B | 25.86B |
| Retained Earnings | 7.21B | 4.59B |
| Retained Earnings % of Revenue | 105.9% | 10.4% |
| Property, Plant & Equipment | 314.88M | 8.81B |
Cash Flow Statement Comparison
| Metric | VIJAYA (2025) | STAR (2025) |
|---|---|---|
| Operating Cash Flow | 2.04B | 36.02B |
| Operating Cash Flow % of Revenue | 30.0% | 82.0% |
| Capital Expenditures | -926.14M | 681.03M |
| Free Cash Flow | 1.29B | 4.42B |
| FCF Margin | 18.9% | 10.1% |
| Debt Repayment | N/A | -3.20B |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | VIJAYA | STAR |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 102.90M | 92.17M |
| Float Shares | 48.82M | 56.69M |
| % Held by Insiders | 52.51% | 30.78% |
| % Held by Institutions | 34.14% | 26.99% |
| % Held by Public | 13.35% | 42.23% |
Dividend Analysis & Yield Comparison: Vijaya Diagnostic Centre Ltd. vs Strides Pharma Science Ltd.
| Metric | VIJAYA | STAR |
|---|---|---|
| Last 12-Month Dividend | ₹3.00 | ₹6.50 |
| Last 12-Month Dividend Yield | 0.30% | 0.74% |
| 3-Year Avg Annual Dividend | ₹1.67 | ₹2.67 |
| 3-Year Avg Dividend Yield | 0.19% | 0.32% |
| 3-Year Total Dividends | ₹5.00 | ₹8.00 |
| Ex-Dividend Date | Aug 29, 2025 | Jul 22, 2025 |